Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Alterations of the WNT7A gene in clear cell renal cell carcinomas.

Kondratov AG, Kvasha SM, Stoliar LA, Romanenko AM, Zgonnyk YM, Gordiyuk VV, Kashuba EV, Rynditch AV, Zabarovsky ER, Kashuba VI.

PLoS One. 2012;7(10):e47012. doi: 10.1371/journal.pone.0047012. Epub 2012 Oct 8.

3.

Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.

Cancer Res. 2001 Oct 1;61(19):7277-81.

4.

Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Sun JZ, Yang XX, Li XH, Xu WW, Wang Y, Zhu W, Li M.

Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30.

PMID:
21448695
5.

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.

Kondo K, Yao M, Yoshida M, Kishida T, Shuin T, Miura T, Moriyama M, Kobayashi K, Sakai N, Kaneko S, Kawakami S, Baba M, Nakaigawa N, Nagashima Y, Nakatani Y, Hosaka M.

Genes Chromosomes Cancer. 2002 May;34(1):58-68.

PMID:
11921283
6.

Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.

Xu B, Zhang L, Luo C, Qi Y, Cui Y, Ying JM, Zhang Q, Jin J.

Int J Mol Sci. 2015 Jan 5;16(1):1051-65. doi: 10.3390/ijms16011051.

7.

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.

Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, Wang LD, Yang CS.

Carcinogenesis. 2001 Oct;22(10):1615-23.

8.

Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer.

Tennis MA, Vanscoyk MM, Wilson LA, Kelley N, Winn RA.

PLoS One. 2012;7(3):e32921. doi: 10.1371/journal.pone.0032921. Epub 2012 Mar 5.

9.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

10.

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Tong JH, Ng DC, Chau SL, So KK, Leung PP, Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, To KF.

BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.

11.

Methylation-associated silencing of TU3A in human cancers.

Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O.

Int J Oncol. 2008 Oct;33(4):893-9.

PMID:
18813805
12.

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

Lv D, Zhao W, Dong D, Qian XP, Zhang Y, Tian XJ, Zhang J.

Eur J Cancer. 2011 Sep;47(13):2068-76. doi: 10.1016/j.ejca.2011.04.021. Epub 2011 May 18.

PMID:
21600761
13.

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.

Dallol A, Forgacs E, Martinez A, Sekido Y, Walker R, Kishida T, Rabbitts P, Maher ER, Minna JD, Latif F.

Oncogene. 2002 May 2;21(19):3020-8.

14.

The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.

Chan SL, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H, Ng KM, Wang Y, Lee KY, Tsao GS, Zhong S, Robertson KD, Rha SY, Chan AT, Tao Q.

Lab Invest. 2007 Jul;87(7):644-50. Epub 2007 Mar 26.

15.

Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.

Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):557-64.

16.
17.

Methylation-associated silencing of SFRP1 in renal cell carcinoma.

Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O.

Oncol Rep. 2008 Nov;20(5):1257-63.

PMID:
18949430
18.

Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.

Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.

Hepatology. 2012 Nov;56(5):1817-27. doi: 10.1002/hep.25870. Epub 2012 Oct 14.

PMID:
22689435
19.

Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.

Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.

Mol Carcinog. 2003 Dec;38(4):170-8.

PMID:
14639656
20.

Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.

Kim M, Lee KT, Jang HR, Kim JH, Noh SM, Song KS, Cho JS, Jeong HY, Kim SY, Yoo HS, Kim YS.

Mol Cancer Res. 2008 Feb;6(2):222-30. doi: 10.1158/1541-7786.MCR-07-0142.

Items per page

Supplemental Content

Write to the Help Desk